Cigna Adopts $0 Stelara Biosimilar Program More Rapidly Than For Humira

Move To Make Ustekinumab Available Via Accredo Follows Similar Adalimumab Initiative

 
• By Dave Wallace
  
Zero point zero zero dollars in neon with box
Evernorth will offer a Stelara biosimilar at $0 out of pocket • Source: Shutterstock

More from Biosimilars

More from Products